Comprehensive Education-Based Mental Health Services for Students Diagnosed on the Autism Spectrum

  • Raymond W. DuCharme
  • Kathleen A. McGrady
  • Jayantkumar C. Patel
  • Gualberto Ruaño
Part of the Issues in Children's and Families' Lives book series (IICL)


The purpose of this chapter is to describe clinical strategies that parents and professionals can use to improve treatments provided to students on the autism spectrum. The focus of the chapter is to explain the complexity of treatments that may be effective with Asperger students and others on the spectrum.


Toxicity Depression Schizophrenia Serotonin Risperidone 


  1. Black, J. L., III, O’Kane, D. J., & Mrazek, D. A. (2007). The impact of CYP allelic variation on antidepressant metabolism: A review. Expert Opinion on Drug Metabolism & Toxicology, 3(1), 21–31.CrossRefGoogle Scholar
  2. Kim, S., Leventhal, B. L., Koh, Y. J., Fombonne, E., Laska, E., Lim, E. C., et al. (2011). Prevalence of autism spectrum disorders in a total population sample. The American Journal of Psychiatry, 168(9), A54.CrossRefGoogle Scholar
  3. Klin, A., Volkmar, F. R., & Sparrow, S. S. (2000). Asperger syndrome psychopharmacological treatment of higher functioning pervasive developmental disorders (p. 219). New York: Guilford Press.Google Scholar
  4. Malhotra, A. K., Goldman, D., & Mazzanti, C. (1998). A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Molecular Psychiatry, 3, 328–332.PubMedCrossRefGoogle Scholar
  5. Malhotra, A. K., Murphy, G. M., & Kennedy, J. L. (2004). Pharmacogenetics of psychotropic drug response. The American Journal of Psychiatry, 161(5), 780–796.PubMedCrossRefGoogle Scholar
  6. Mattila, M. L., Hurtig, T., Haapsamo, H., Jussila, K., Kuusikko-Gauffin, S., Kielinen, M., et al. (2010). Comorbid psychiatric disorders associated with Asperger syndrome high-functioning autism: A community- and clinic-based study. Journal of Autism and Developmental Disorders, 40(9), 1080–1093.PubMedCrossRefGoogle Scholar
  7. Mefford, H., & Eichler, E. E. (2009). Duplication hotspots, rare genomic disorders, and common disease. Genetics and Development, 19(3), 196–204.Google Scholar
  8. Mesibov, G. B., Shea, V., & Adams, L. W. (2001). Understanding asperger syndrome and high functioning autism. New York: Kluwer Academic/Plenum.Google Scholar
  9. Mrazek, D. A. (2010). Psychiatric pharmacogenomics (pp. 39–53). New York: Oxford University Press.CrossRefGoogle Scholar
  10. National Human Genome Research Institute. (2012). Frequently asked questions about genetic testing. Retrieved October 13, 2011, from
  11. Ruaño, G., Villagra, D., Rahim, U.-S., Windemuth, A., Kocherla, M., & Bower, B. (2008). Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital. Personalized Medicine, 5, 579–587.CrossRefGoogle Scholar
  12. Ruaño, G., Villagra, D., Szarek, B., Windemuth, A., Kocherla, M., Gorowski, K. (2011). Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients. Biomarkers in Medicine, 5(4), 439–449.PubMedCrossRefGoogle Scholar
  13. Salyakina, D., Ma, D. Q., Jaworski, J. M., Konidari, I., Whitehead, P. L., Henson, R., et al. (2010). Variants in several genomic regions associated with asperger disorder. Autism Research, 3(6), 303–310.PubMedCrossRefGoogle Scholar
  14. Singer, E. (2009a). Interpreting the genome. MIT Technology Review, 112(1), 48–53.Google Scholar
  15. Singer, E. (March/April, 2009b). A hole in the genome. Technology Review. Retrieved September 19, 2012, from
  16. Shute, N., & Christie, B. (2010). Desperate for an autism cure. Scientific American, 303(6), 80–85.PubMedCrossRefGoogle Scholar
  17. Smith, B. L. (2012). Inappropriate prescribing. Monitoring on Psychology, 43(6), 38–40.Google Scholar
  18. The Learning Clinic. (2011). Preliminary findings for TLC applied research: Results of pharmacology-genotyping among TLC students. Retrieved September 19, 2012, from
  19. Villagra, D., Goethe, J., Schwartz, H. I., Szarek, B., Kocherla, M., Gorowski, K., et al. (2011) Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes. Biomarkers in Medicine, 5(4), 427–438.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Raymond W. DuCharme
    • 1
  • Kathleen A. McGrady
    • 1
  • Jayantkumar C. Patel
    • 2
  • Gualberto Ruaño
    • 3
  1. 1.The Learning ClinicBrooklynUSA
  2. 2.United Services, IncWillimanticUSA
  3. 3.Genetics Research CenterHartford HospitalHartfordUSA

Personalised recommendations